FDA Approves Eli Lilly’s GLP-1 Pill
Short excerpt below. Click through to read at the original source.
Eli Lilly’s once-daily Foundayo is the second obesity pill to receive FDA approval. It will compete with Novo Nordisk’s pill version of Wegovy.
Short excerpt below. Click through to read at the original source.
Eli Lilly’s once-daily Foundayo is the second obesity pill to receive FDA approval. It will compete with Novo Nordisk’s pill version of Wegovy.